Lacosamide

Drug ingredient

CAS 175481-36-4

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 175481-36-4
US productionNot reported
Import value, 2024$872M
Top sourceSwitzerland 44%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 292429 · basket

These shares come from HS customs code 292429, which covers 203 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries
CH 44%SwitzerlandCN 19%ChinaIN 12%IndiaJP 9%JapanIE 6%Ireland
74 FDA-registered drug labelers
Advanced Rx of Tennessee, LLC
Ajenat Pharmaceuticals LLC
Alembic Pharmaceuticals Inc.
Alembic Pharmaceuticals Limited
Alivus Life Sciences Limited
American Health Packaging
Amneal Pharmaceuticals of New York LLC
ANI Pharmaceuticals, Inc.
Anthea Pharma Private Limited
Apotex Corp
Ascend Laboratories, LLC
Aucta Pharmaceuticals, Inc.
Aurobindo Pharma Limited
Breckenridge Pharmaceutical, Inc.
Camber Pharmaceuticals, Inc.
CAMBREX PROFARMACO MILANO SRL
Catalent Pharma Solutions, LLC
Chartwell Governmental & Specialty RX, LLC.
Chartwell RX, LLC
Chieron Active Ingredients Private Limited
Chongqing Bioland Pharmaceutical Ltd.
Clinical Solutions Wholesale, LLC
Coupler LLC
Curia Missouri Inc.
Divi's Laboratories Limited
Dr. Reddy's Laboratories Inc.
EMNAR PHARMA PRIVATE LIMITED
Florida Pharmaceutical Products, LLC
Fosun Pharma USA
Fresenius Kabi USA, LLC
Gland Pharma Limited
Glenmark Pharmaceuticals Inc. USA
Glenmark Pharmaceuticals Limited
Golden State Medical Supply, Inc.
Hetero Drugs Limited
HIKAL LIMITED
Indoco Remedies Limited
Jubilant Biosys limited
Kanchan Healthcare Inc
Kesin Pharma Corporation
Kesin Pharmaceutical Corporation
Leading Pharma, LLC
Macleods Pharmaceuticals Limited
Major Pharmaceuticals
Marlex Pharmaceuticals, Inc
Metrochem API Private Limited
MSN LABORATORIES PRIVATE LIMITED
MSN Pharmachem Private Limited
NorthStar Rx LLC
Novadoz Pharmaceuticals LLC
PAI Holdings, LLC dba PAI Pharma
Patheon Italia S.p.A
Precision Dose, Inc.
Proficient Rx LP
REMEDYREPACK INC.
Sagent Pharmaceuticals
ScieGen Pharmaceuticals Inc
SIEGFRIED AG
Sintetica US LLC
Somerset Therapeutics, LLC
Sun Pharmaceutical Industries, Inc.
Trigen Laboratories, LLC
Tris Pharma Inc
UCB Pharma SA
UCB, Inc.
Unichem Laboratories Limited, India
Unichem Pharmaceuticals (USA), Inc.
Virtus Pharmaceuticals, LLC
Viyash Life Sciences Private Limited
Westminster Pharmaceuticals, LLC
Wisdom Pharmaceutical Co.,Ltd.
XLCare Pharmaceuticals Inc.
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 4 drug and cosmetic product listings (FDA).

  • •Lacosamide
  • •Lacosamide Oral Solution
  • •Vimpat
  • •Motpoly XR
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS175481-36-4
PubChem CID219078
DTXSIDDTXSID1057666
FormulaC13H18N2O3
Mol. Weight250.29 g/mol
SMILESCC(=O)NC(COC)C(=O)NCC1=CC=CC=C1

Data Sources

Brief citations

Lacosamide (CAS 175481-36-4) https://chemicalindependence.com/chemical/175481-36-4/ PubChem: 219078. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/219078 FDA National Drug Code directory: CAS 175481-36-4. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/ US Census international trade: HS 292429 for CAS 175481-36-4. Reporting year: 2024. https://usatrade.census.gov/